Perjeta Intravenous infusion 420mg/14mL, manufactured by Chugai Pharmaceutical, contains Pertuzumab (genetical recombination). With YJ code 4291424A1020 and standard 420mg 14mL bottle, it is a monoclonal antibody used in combination with other agents to treat HER2-positive breast cancer.
Perjeta Intravenous infusion 420mg/14mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →